LAKE HILLS PHARMACY FORMULATION
Modified Growth Hormone Releasing Hormone

All content on this page has been clinically reviewed and approved by board-certified physicians.
Preclinical and animal studies with limited human data
Concentration
1mg CJC-1295 / 1mg Ipamorelin per mL (Injectable). Combined product - not sold separately.
Available Vial Sizes
5mL vial, RDT package, Suspension bottle
Route of Administration
Subcutaneous (SC)
Storage
Refrigerate 2-8°C
Note: CJC-1295 is typically compounded as a combination product with Ipamorelin for enhanced growth hormone release. Please consult with your provider for the most appropriate formulation.
Teichman SL, et al. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults J Clin Endocrinol Metab. 2006 PMID: 16449330
Jetté L, et al. CJC-1295, a long-acting growth hormone-releasing hormone analog, improves sleep quality in adult growth hormone deficiency J Clin Endocrinol Metab. 2007 PMID: 17595250
General Information: Accessible overview for patients and healthcare consumers. Switch to Clinical View for complete medical protocols.
These peptides are not FDA-approved but are commonly used by providers and patients under medical supervision. These statements have not been evaluated by the FDA. These products are not intended to diagnose, treat, cure, or prevent any disease. We provide evidence-based information from current research to help navigate this evolving field. Our goal is to ensure access to safe, pure, potent products under professional oversight—not unregulated substances purchased online.
Lake Hills Pharmacy | Licensed Compounding Pharmacy | Professional Medical Oversight Required